{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:26:21Z","timestamp":1777530381656,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T00:00:00Z","timestamp":1313625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s10620-011-1861-1","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T14:06:26Z","timestamp":1313589986000},"page":"210-214","source":"Crossref","is-referenced-by-count":12,"title":["Hepatorenal Syndrome: Are We Missing Some Prognostic Factors?"],"prefix":"10.1007","volume":"57","author":[{"given":"Marco Olivera","family":"Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harlan","family":"Sayles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renuga","family":"Vivekanandan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharlene","family":"D\u2019 Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius C.","family":"Florescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,18]]},"reference":[{"key":"1861_CR1","first-page":"1310","volume":"56","author":"F Salerno","year":"2007","unstructured":"Salerno F, Gerbes A, Gin\u00e9s P, Wong F, Arroyo V. Diagnosis prevention and treatment of the hepatorenal syndrome in cirrhosis: a consensus workshop of the international ascites club. Gut. 2007;56:1310\u20131318.","journal-title":"Gut"},{"key":"1861_CR2","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"B Runyon","year":"2009","unstructured":"Runyon B. Management of adult patients with ascites due to cirrhosis. Hepatology. 2009;49:2087\u20132107.","journal-title":"Hepatology"},{"key":"1861_CR3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","volume":"105","author":"A Gines","year":"1993","unstructured":"Gines A, Escorsell A, Gines P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993;105:229\u2013236.","journal-title":"Gastroenterology"},{"key":"1861_CR4","first-page":"164","volume":"23","author":"V Arroyo","year":"1996","unstructured":"Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Int Ascites Club Hepatol. 1996;23:164\u2013176.","journal-title":"Int Ascites Club Hepatol"},{"key":"1861_CR5","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","volume":"362","author":"P Gines","year":"2003","unstructured":"Gines P, Guevara M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet. 2003;362:1819\u20131827.","journal-title":"Lancet"},{"key":"1861_CR6","doi-asserted-by":"crossref","unstructured":"Wadei HM, Mai ML, Ahsan N, Gonwa TA. Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol. 2006;1:1066\u20131079. doi: 10.2215\/CJN.01340406 .","DOI":"10.2215\/CJN.01340406"},{"key":"1861_CR7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1440-1746.2002.02816.x","volume":"17","author":"I Colle","year":"2002","unstructured":"Colle I, Durand F, Pessione F, et al. Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis. J Gastroenterol Hepatol. 2002;17:882\u2013888.","journal-title":"J Gastroenterol Hepatol"},{"key":"1861_CR8","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/j.1572-0241.2002.05920.x","volume":"97","author":"K Watt","year":"2002","unstructured":"Watt K, Uhanova J, Minuk GY. Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center. Am J Gastroenterol. 2002;97:2046\u20132050.","journal-title":"Am J Gastroenterol"},{"key":"1861_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","volume":"40","author":"F Wong","year":"2004","unstructured":"Wong F, Pantea L, Sniderman K. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology. 2004;40:55\u201364.","journal-title":"Hepatology"},{"key":"1861_CR10","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1111\/j.1572-0241.2005.00271.x","volume":"100","author":"J Peron","year":"2005","unstructured":"Peron J, Bureau C, Gonzalez L, et al. Treatment of hepatorenal syndrome as defined by the International Ascites Club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study. Am J Gastroenterol. 2005;100:2702\u20132707.","journal-title":"Am J Gastroenterol"},{"key":"1861_CR11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.1840200215","volume":"20","author":"JF Platt","year":"1994","unstructured":"Platt JF, Ellis JH, Rubin JM, Merion RM, Lucey MR. Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease. Hepatology. 1994;20:362\u2013369.","journal-title":"Hepatology"},{"key":"1861_CR12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/hep.20832","volume":"42","author":"K Lenz","year":"2005","unstructured":"Lenz K. Hepatorenal syndrome: is it central hypovolemia, a cardiac disease, or part of gradually developing multiorgan dysfunction? Hepatology. 2005;42:263\u2013265.","journal-title":"Hepatology"},{"key":"1861_CR13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCG.0b013e318188947c","volume":"43","author":"C Skagen","year":"2009","unstructured":"Skagen C, Einstein M, Lucey MR, Said A. Combination treatment with octreotide, midodrine and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome. J Clin Gastroenterol. 2009;43:680\u2013685.","journal-title":"J Clin Gastroenterol"},{"key":"1861_CR14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/08860229509026250","volume":"17","author":"F Keller","year":"1995","unstructured":"Keller F, Heinze H, Jochimsen F, Passfall J, Schuppan D, Buttner P. Risk factors and outcome of 107 patients with decompensated liver disease and acute renal failure (including 26 patients with hepatorenal syndrome): the role of hemodialysis. Ren Fail. 1995;17:135\u2013146.","journal-title":"Ren Fail"},{"key":"1861_CR15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1081\/JDI-200035988","volume":"26","author":"RK Capling","year":"2004","unstructured":"Capling RK, Bastani B. The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis. Ren Fail. 2004;26:563\u2013568.","journal-title":"Ren Fail"},{"key":"1861_CR16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1097\/MEG.0b013e32832ec16a","volume":"21","author":"B Appenrodt","year":"2009","unstructured":"Appenrodt B, Zielinski J, Brensing KA, Heller J, Sauerbruch T, Schepke M. Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: a retrospective analysis. Eur J Gastroenterol Hepatol. 2009;21:1428\u20131432.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1861_CR17","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1440-1746.2004.03471.x","volume":"19","author":"O Witzke","year":"2004","unstructured":"Witzke O, Baumann M, Patschan D, et al. Which patients benefit from hemodialysis therapy in hepatorenal syndrome? J Gastroenterol Hepatol. 2004;19:1369\u20131373.","journal-title":"J Gastroenterol Hepatol"},{"key":"1861_CR18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","volume":"122","author":"R Moreau","year":"2002","unstructured":"Moreau R, Durand F, Poynard T, et al. Terlipressin in patients with cirrhosis and type I hepatorenal syndrome: a retrospective multicentric study. Gastroenterology. 2002;122:923\u2013930.","journal-title":"Gastroenterology"},{"key":"1861_CR19","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/hep.21901","volume":"46","author":"A Krag","year":"2007","unstructured":"Krag A, M\u00f8ller S, Henriksen JH, Holstein-Rathlou NH, Larsen FS, Bendtsen F. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Hepatology. 2007;46:1863\u20131871.","journal-title":"Hepatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1861-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-011-1861-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1861-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T04:12:16Z","timestamp":1560485536000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-011-1861-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,18]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1861"],"URL":"https:\/\/doi.org\/10.1007\/s10620-011-1861-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,18]]}}}